Like eager buyers queuing for the latest iPhone, urban Indians are chasing next-generation weight-loss injections regardless of price. Eli Lilly’s Mounjaro has dethroned long-time bestseller Augmentin, sparking an unprecedented market boom for GLP-1 drugs.

See all 387 in Finance →

By

Leave a Reply

Your email address will not be published. Required fields are marked *